Abstract
We report the long-term follow-up of 12 pediatric-aged patients with chronic granulomatous disease (CGD). The mean age at the onset of infections was 5 months with a median delay in diagnosis of 2.5 years. Bacille Calmette–Guérin lymphadenitis was the most common presenting infection (6) followed by suppurative lymphadenitis (4), liver abscess (1), or Salmonella sepsis (1). Prophylaxis with cotrimoxazole was recommended to all patients. During the mean follow-up of 10 years (range, 4–23 years) pneumonitis was the most prevalent infection (91%) followed by lymphadenitis (83%), aphtous stomatitis (58%), and liver abscesses (25%). Seven (58%) patients developed chronic lung disease due to grossly delayed diagnosis (3) or poor compliance with antimicrobial prophylaxis (4). Five (41%) patients died during the second decade of life of aspergillosis (3) or chronic lung disease (2). Probability of survival into the third decade of life was estimated to be only 19%. We argue that HLA-identical bone marrow transplantation (BMT), if possible, should be attempted at early age because of significant morbidity and mortality in adolescence. BMT also should be considered in patients who suffer severe infections despite antimicrobial prophylaxis or patients with evidence of chronic lung disease. Possibility of elective BMT from unrelated donors remains to be carefully evaluated.
Similar content being viewed by others
References
Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM: Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79:170-200, 2000
Margolis DM, Melnick DA, Alling DW, Gallin JI: Trimethoprim–sulphamethoxazole prophylaxis in the management of chronic granulomatous disease. J Infect Dis 16:723-726, 1990
Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A: Long-term itraconazole prophylaxis against Aspergillus infection in thirty-two patients with chronic granulomatous disease. J Pediatr 125:998-1003, 1994
The International Chronic Granulomatous Disease Study Group: A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 324:509-516, 1991
Winkelstein JA, Marino MC, Johnston RB Jr, Boyle J, Curnutte J, Galiin J, Malech HL, Holland SM, Ochs HD, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169, 2000
Hasui M: Chronic granulomatous disease in Japan: Incidence and natural history. The study group of phagocyte disorders of Japan. Pediatr Int 41:589-593, 1999
Grumach AS, Duarte AJS, Bellinati-Pires R, Pastorino AC, Jacob CMA, Diogo CL, Condino-Neto A, Kirschfink M, Carneiro-Sampaio MGS: Brasilian report on primary immunodeficiencies in children: 166 cases studied over follow-up time of 15 years. J Clin Immunol 17:340-345, 1997
Gomez L: Outcome of CGD patients. Mol Immunol 35:760, 1998
Levinsky RJ, Harvey BA, Rodeck CH, Soothill JF: Phorbol myristate acetate stimulated NBT test: A simple method suitable for antenatal diagnosis of chronic granulomatous disease. Clin Exp Immunol 54:595-598, 1983
Pasic S, Abinun M, Vlajic B, Pistignjat B, Rakic J, Sarjanovic LJ, Ostojic N: Aspergillus osteomyelitis in chronic granulomatous disease: Treatment with recombinant gamma-interferon and itraconazole. Ped Infect Dis J 15:833-834, 1996
Johnston RB Jr, McMurray JS: Chronic familial granulomatosis: Report of 5 cases and review of the literature. Am J Dis Child 114:370-378, 1967
Finn A, Hadzic N, Morgan G, Strobel S, Levinsky RJ: Prognosis of chronic granulomatous disease. Arch Dis Child 65:942-945, 1990
Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C: Incidence, severity and prevention of infections in chronic granulomatous disease. J Pediatr 113:555-560, 1989
Mouy R, Seger R, Borquin JP, Veber F, Blanche S, Griscelli C, Fischer A: Interferon gamma for chronic granulomatous disease. N Engl J Med 325:1516, 1991
Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, Gahr M, Belohradsky BH: Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137:687-693, 2000
Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A: Immunological conditions of children with BCG disseminated infection. Lancet 346:581, 1995
Gonzalez B, Moreno S, Burdach R, Valenzuela MT, Henriquez A, Ramos MI, Sorensen RU: Clinical presentation of bacillus Calmette—Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J 8:201-206, 1989
Lekstrom-Himes JA, Gallin JI: Immunodeficiency diseases caused by defects in phagocytes. N Engl J Med 343:1703-1714, 2000
Lamahmedi-Cherradi S, de Chastellier C, Casanova JL: Growth of Mycobacterium bovis, bacille Calmette—Guérin, within human monocytes—macrophages cultured in serum-free medium. J Immunol Methods 225:75-86, 1999
Foster CB, Lehrnbecher T, Mol F, Steinberg SM, Venzon DJ, Walsh TJ, Noack D, Rae J, Winkelstein JA, Curnutte JT, Chanock SJ: Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 102:2146-2155, 1998
Kobayashi Y, Komizawa Y, Kobayashi M, Matsumoto T, Sukura N, Ishikawa K, Usui T: Presumed BCG infection in a boy with chronic granulomatous disease. A report of a case and a review of the literature. Clin Pediatr 23:586-589, 1984
Eppinger TM, Greenberger PA, White DA, Brown AE: Senzitisation to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Aller Clin Immunol 104:1265-1272, 1999
Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O: Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Aller Clin Immunol 104:1031-1036, 1999
Cale CM, Jones AM, Goldblatt DA: Follow-up of patients with chronic granulomatous disease diagnosed since 1990. Clin Exp Immunol 120:351-355, 2000
The Westminster Hospitals Bone-marrow Transplant Team: Bone-marrow transplant from an unrelated donor. Lancet 1:210-213, 1977
Kamani N, August CS, Campbell DE, Hassan NF, Douglas SD: Marrow transplantation in chronic granulomatous disease: An update, with 6-year follow-up. J Pediatr 113:697-700, 1988
Leung T, Chic K, Li C, Shing M, Yuen P: Bone marrow transplantation for chronic granulomatous disease: Long-term follow-up and review of literature. Bone Marrow transplant 24:567-570, 1999
Hobbs JR, Monteil M, McCluskey DR, Jurges E, el Tumi M: Chronic granulomatous disease 100% corrected by displacement bone marrow transplantation from a volunteer unrelated donor. Eur J Pediatr 151:806-810, 1992
Ho CM, Vowels MR, Lockwood L, Ziegler JB: Successful bone marrow transplantation in a child with X-linked chronic granulomatous disease. Bone Marrow Transplant 18:213-215, 1996
Di Bartolomeo P, Di Girolamo G, Angrilli F, Schettini F, De Mattia D, Manzionna MM, Dragani A, Iacone A, Torlontano G: Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant 4:695-700, 1989
Gennery AR, Bunn J, Barge D, Abinun M, Cant AJ, Flood TJ: Successful HLA identical bone marrow transplantation in a boy with X-linked chronic granulomatous disease and chronic lung disease. Mol Immunol 35:775, 1998
Ohzahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsachin M, Crompton NE, Seger RA: Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte-colony stimulating factor-mobilized granulocytes and liposomal amphotericin B. Blood 15:2719-2724, 1998
Bielorai B, Toren A, Wolach B, Mandel M, Golan H, Neumann Y, Kapilinsky C, Weintraub M, Keller N, Amaraglio N, Paswell J, Rechavi G: Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant 26:1025-1028, 2000
Nagler A, Ackerstein A, Kapelushnik J, Or R, Naparstek E, Slavin S: Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease. Bone Marrow Transplant 24:339-342, 1999
Horwitz ME, Barrett AJ, Brown MR, Carter CS, Childs R, Gallin JI, Holland SM, Linton GF, Miller JA, Leitman SF, Read EJ, Malech HL: Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell depleted hematopoietic allograft. N Engl J Med 344:881-888, 2001
Trasher A, Goldblatt D: Hematopoietic-cell trasplantation for chronic granulomatous disease. N Engl J Med 345:377, 2001
Porta F, Friedrich W: Bone marrow transplantation in congenital immunodeficiency diseases. Bone Marrow Transplant 21(Suppl 2):21-23, 1998
Fischer A, Segal AW, Seger RA, Weening RS: The management of chronic granulomatous disease. Eur J Pediatr 52:896-899, 1993
Porta F, Mazzolari E, Verzeri U, Schumacher F, Lanfranchi A, Verardi R: Matched unrelated transplant in an infant affected by chronic granulomatous disease. Bone Marrow Transplant 25:S190, 2000
Watanabe C, Yajima S, Taguchi T, Toya K, Fujii Y, Hongo T, Ohzeki T: Successful unrelated bone marrow transplantation for a patient with chronic granulomatous disease and associated resistant pneumonitis and Aspergillus osteomyelitis. Bone Marrow Transplant 28:83-87, 2001
Fischer A, Landais P, Friedrich W, et al.: Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency. Blood 83:1149-1154, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pasic, S., Minic, A., Minic, P. et al. Long-Term Follow-Up and Prognosis of Chronic Granulomatous Disease in Yugoslavia: Is There a Role for Early Bone Marrow Transplantation?. J Clin Immunol 23, 55–61 (2003). https://doi.org/10.1023/A:1021952315651
Issue Date:
DOI: https://doi.org/10.1023/A:1021952315651